Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 2
2005 3
2006 2
2007 3
2008 2
2009 7
2010 4
2011 8
2012 6
2013 5
2014 8
2015 4
2016 13
2017 16
2018 13
2019 9
2020 5
2021 8
2022 8
2023 3
2024 12
2025 10
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Results by year

Filters applied: . Clear all
Page 1
Combining TIGIT Blockade with MDSC Inhibition Hinders Breast Cancer Bone Metastasis by Activating Antitumor Immunity.
Monteran L, Ershaid N, Scharff Y, Zoabi Y, Sanalla T, Ding Y, Pavlovsky A, Zait Y, Langer M, Caller T, Eldar-Boock A, Avivi C, Sonnenblick A, Satchi-Fainaro R, Barshack I, Shomron N, Zhang XH, Erez N. Monteran L, et al. Among authors: satchi fainaro r. Cancer Discov. 2024 Jul 1;14(7):1252-1275. doi: 10.1158/2159-8290.CD-23-0762. Cancer Discov. 2024. PMID: 38427556
Immune-mediated approaches against COVID-19.
Florindo HF, Kleiner R, Vaskovich-Koubi D, Acúrcio RC, Carreira B, Yeini E, Tiram G, Liubomirski Y, Satchi-Fainaro R. Florindo HF, et al. Among authors: satchi fainaro r. Nat Nanotechnol. 2020 Aug;15(8):630-645. doi: 10.1038/s41565-020-0732-3. Epub 2020 Jul 13. Nat Nanotechnol. 2020. PMID: 32661375 Free PMC article. Review.
Better, Faster, Stronger: Accelerating mRNA-Based Immunotherapies With Nanocarriers.
Carvalho HMB, Fidalgo TAS, Acúrcio RC, Matos AI, Satchi-Fainaro R, Florindo HF. Carvalho HMB, et al. Among authors: satchi fainaro r. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Nov-Dec;16(6):e2017. doi: 10.1002/wnan.2017. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024. PMID: 39537215 Free PMC article. Review.
Emerging Nanomedical Solutions for Angiogenesis Regulation.
Blau R, Neeman M, Satchi-Fainaro R. Blau R, et al. Among authors: satchi fainaro r. Adv Drug Deliv Rev. 2017 Sep 15;119:1-2. doi: 10.1016/j.addr.2017.11.004. Adv Drug Deliv Rev. 2017. PMID: 29162250 No abstract available.
Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cells.
Madan E, Palma AM, Vudatha V, Kumar A, Bhoopathi P, Wilhelm J, Bernas T, Martin PC, Bilolikar G, Gogna A, Peixoto ML, Dreier I, Araujo TF, Garre E, Gustafsson A, Dorayappan KDP, Mamidi N, Sun Z, Yekelchyk M, Accardi D, Olsen AL, Lin L, Titelman AA, Bianchi M, Jessmon P, Farid EA, Pradhan AK, Neufeld L, Yeini E, Maji S, Pelham CJ, Kim H, Oh D, Rolfsnes HO, Marques RC, Lu A, Nagane M, Chaudhary S, Gupta K, Gogna KC, Bigio A, Bhoopathi K, Mannangatti P, Achary KG, Akhtar J, Belião S, Das S, Correia I, da Silva CL, Fialho AM, Poellmann MJ, Javius-Jones K, Hawkridge AM, Pal S, Shree KS, Rakha EA, Khurana S, Xiao G, Zhang D, Rijal A, Lyons C, Grossman SR, Turner DP, Pillappa R, Prakash K, Gupta G, Robinson GLWG, Koblinski J, Wang H, Singh G, Singh S, Rayamajhi S, Bacolod MD, Richards H, Sayeed S, Klein KP, Chelmow D, Satchi-Fainaro R, Selvendiran K, Connolly D, Thorsen FA, Bjerkvig R, Nephew KP, Idowu MO, Kühnel MP, Moskaluk C, Hong S, Redmond WL, Landberg G, Lopez-Beltran A, Poklepovic AS, Sanyal A, Fisher PB, Church GM, Menon U, Drapkin R, Godwin AK, Luo Y, Ackermann M, Tzankov A, Mertz KD, Jonigk D, Tsung A, Sidransky D, Trevino J, Saavedra AP, Winn R, Won KJ, Moreno E, Gogna … See abstract for full author list ➔ Madan E, et al. Among authors: satchi fainaro r. Nat Biotechnol. 2025 Nov;43(11):1833-1847. doi: 10.1038/s41587-024-02453-3. Epub 2024 Dec 9. Nat Biotechnol. 2025. PMID: 39653752
My greatest experiment.
Satchi-Fainaro R. Satchi-Fainaro R. Nat Nanotechnol. 2018 Feb;13(2):176. doi: 10.1038/s41565-018-0064-8. Nat Nanotechnol. 2018. PMID: 29403044 No abstract available.
Cancer Organoids as reliable disease models to drive clinical development of novel therapies.
Blandino G, Satchi-Fainaro R, Tinhofer I, Tonon G, Heilshorn SC, Kwon YJ, Pestana A, Frascolla C, Pompili L, Puce A, Iachettini S, Tocci A, Karkampouna S, Kruithof-de Julio M, Tocci P, Porciello N, Maccaroni K, Rutigliano D, Shen X, Ciliberto G. Blandino G, et al. Among authors: satchi fainaro r. J Exp Clin Cancer Res. 2024 Dec 28;43(1):334. doi: 10.1186/s13046-024-03258-7. J Exp Clin Cancer Res. 2024. PMID: 39731178 Free PMC article.
Patient-Derived 3D-Bioprinted Models of Pancreatic Cancer: Toward Personalized Therapy and Overcoming Tumor Microenvironment Challenges.
Vaskovich-Koubi D, Green Buzhor M, Krinsky A, Roth Y, Salomon K, Kleiner R, Sevostianov R, Hasin O, Khoury R, Satchi-Fainaro R. Vaskovich-Koubi D, et al. Among authors: satchi fainaro r. Adv Drug Deliv Rev. 2025 Oct;225:115670. doi: 10.1016/j.addr.2025.115670. Epub 2025 Aug 7. Adv Drug Deliv Rev. 2025. PMID: 40783053 Free article. Review.
143 results